2026 CBP ACE & FDA OASIS Enforcement Update: MoCRA Cosmetic FEI & QMSR Device 510(k) Affirmation of Compliance cross-checks are active at Los Angeles, Newark, Miami & Savannah ports.
FEILookup · DWPERadarFEI + OASIS + 483
CHARGE CODE: INSANITARY_CONDITIONSFD&C Act Section 402(a)(4) / 501(a)(2)(A)Severity Weight: 9/10
✕ Form FDA 766 Relabeling Ineligible

Adulterated: Prepared, packed, or held under insanitary conditions whereby it may have become contaminated

Statutory & CFR Citation: 21 U.S.C. § 342(a)(4) (Food/Supplement) • 21 U.S.C. § 351(a)(2)(A)-(B) (Drug/cGMP) • Associated Import Alert 66-40 / Import Alert 99-39
Plain-English Importer Translation:

An FDA foreign inspection (Form FDA 483) or cGMP audit found systemic facility sanitation failures, non-sterile ophthalmic/OTC water systems, or pest harborage.

Typical Port Detention Window
30–60+ calendar days
Estimated Defense / Lab Cost
$8,500 – $22,000 (cGMP CAPA remediation & Import Alert petition)
Primary Import Alert Trigger
Import Alert 66-40 / Import Alert 99-39

Form FDA 766 Relabeling / Reconditioning Playbook

NOT ELIGIBLE FOR FORM 766 OR SINGLE-LOT LAB RELEASE WHEN UNDER cGMP IMPORT ALERT 66-40: Because Section 402(a)(4) / 501(a)(2)(A) means the product 'may have become contaminated' due to systemic plant conditions, finished-product testing alone usually cannot overcome a cGMP Import Alert 66-40 detention.

Step-by-Step CBP & FDA ITACS Response Sequence:

  1. 1Determine immediately whether detention stems from a facility-wide Form FDA 483 / Warning Letter (Import Alert 66-40 or 99-39) or a container-level sanitation failure.
  2. 2If facility-wide cGMP DWPE applies, demand the factory's Establishment Inspection Report (EIR) and CAPA closure documentation before paying any remaining supplier invoices.
  3. 3For sterile ophthalmic/OTC products, commission USP <71> Sterility and USP <85> Bacterial Endotoxins testing while counsel negotiates with CDER Office of Manufacturing Quality.
  4. 4File a formal Import Alert Removal Petition once third-party cGMP re-inspection confirms all Form 483 observations are closed.

Private Lab Packet (PLAP) & Importer Checklist

Required Analytical / Regulatory Protocol:

Third-party cGMP / 21 CFR 211 / 21 CFR 111 on-site mock FDA audit + USP <71> Sterility / USP <61> Microbial Enumeration.

Pre-Shipment & Post-Detention Verification Checklist:
  • Obtain the overseas manufacturer's full Form FDA 483 Establishment Inspection Report (EIR) and CAPA response timeline.
  • Verify whether the facility has been placed on Import Alert 66-40 (cGMP Drug/OTC) or 99-39 before shipping additional containers.
  • Retain US FDA regulatory counsel to submit an independent cGMP verification audit and petition for removal from DWPE.
Historical OASIS Enforcement Precedents

Overseas Suppliers Cited for INSANITARY_CONDITIONS (1)

TIER 2 • PROCUREMENT DATA & REAL-TIME OASIS WEBHOOK MONITORFEI #3015092811 • Instant Delivery
5-Year Cleaned Excel Pack$39 One-Time

Download Normalized 5-Year Refusal, 483 & Recall Audit Workbook (.XLSX + CSV)

Includes all deduplicated overseas factory names, FEI/DUNS crosswalks, 5-year port refusal logs, plain-English statutory violation mappings, and FSVP supplier qualification templates ready for customs broker review.

  • Full 5-year OASIS refusal history for Ahmedabad Sterile Ophthalmics & Pharma Ltd. + category peers
  • 21 CFR 1.505 Foreign Supplier Verification Program (FSVP) audit checklist tab
FEI #3015092811 Watchdog$15 / month

Instant Supplier Detention Webhook & Email Alert Monitor

Get an automated Slack/Webhook JSON payload and email alert within 15 minutes whenever FDA OASIS logs a new detention, Import Alert Red List addition, or Warning Letter for Ahmedabad Sterile Ophthalmics & Pharma Ltd. before you wire your 70% balance payment.

Enter a corporate email address to receive FEI #3015092811 detention alerts.

Please enter a valid work email address (e.g., ops@company.com).

Optional HTTPS endpoint for automated JSON refusal payloads.

Please enter a valid https:// webhook URL or leave blank.

Charge Code INSANITARY_CONDITIONS FAQ

What does FDA Charge Code INSANITARY_CONDITIONS (FD&C Act Section 402(a)(4) / 501(a)(2)(A)) mean on a Notice of FDA Action?

Adulterated: Prepared, packed, or held under insanitary conditions whereby it may have become contaminated. In plain English: An FDA foreign inspection (Form FDA 483) or cGMP audit found systemic facility sanitation failures, non-sterile ophthalmic/OTC water systems, or pest harborage.

Can a shipment detained for INSANITARY_CONDITIONS be released via Form FDA 766 relabeling?

NOT ELIGIBLE FOR FORM 766 OR SINGLE-LOT LAB RELEASE WHEN UNDER cGMP IMPORT ALERT 66-40: Because Section 402(a)(4) / 501(a)(2)(A) means the product 'may have become contaminated' due to systemic plant conditions, finished-product testing alone usually cannot overcome a cGMP Import Alert 66-40 detention. Final authorization always rests with the reviewing FDA District Import Compliance Office.